Stimulatory Effect of Insulin-Like Growth Factor Binding Protein-5 on Mouse Osteoclast Formation and Osteoclastic Bone-Resorbing Activity-Reference-Cited by-同舟云学术

Stimulatory Effect of Insulin-Like Growth Factor Binding Protein-5 on Mouse Osteoclast Formation and Osteoclastic Bone-Resorbing Activity

Published:2010-02-18 Issue:5 Volume:15 Page:902-910
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Kanatani Masanori,Sugimoto Toshitsugu,Nishiyama Katsuhito,Chihara Kazuo

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference43 articles.

1. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication;Hock;Endocrinology,1988

2. Cellular and clinical perspectives on skeletal insulin-like growth factor I;Delany;J Cell Biochem,1994

3. Insulin-like growth factor binding proteins;Rechler;Vitam Horm,1993

4. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific;Hassager;J Clin Endocrinol Metab,1992

5. Glucocorticoid regulation of insulin- like growth factor binding protein expression in normal human osteoblast-like cells;Okazaki;Endocrinology,1994

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptomics profiling the compatibility mechanism of As2O3-indigo naturalis formula based on bone marrow stroma cells;Biomedicine & Pharmacotherapy;2022-07

2. Single-Cell Transcriptomics Profiling the Compatibility Mechanism of Realgar-Indigo Naturalis Formula (RIF) Based on Steady-State Bone Marrow Stroma Cells;SSRN Electronic Journal;2022

3. Recent Advance in Mammary Gland Remodeling and Its Regulatory Factors;PROG BIOCHEM BIOPHYS;2021

4. A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia;Cell;2019-06

5. A preliminary study on the mechanism of skeletal abnormalities in Turner syndrome using inducing pluripotent stem cells (iPS)-based disease models;Intractable & Rare Diseases Research;2019-05-31